FIELD: medical engineering.
SUBSTANCE: method involves dissolving dry semi-refined polysaccharide in sodium acetate solution with following exposure, treating with phenol mixed with saturated sodium acetate solution, centrifuging, separated upper layer dialysis against calcium chloride solution, depositing with alcohol, centrifuging, separating sediment and its drying. The separated upper layer dialysis product is additionally released from low molecular weight admixtures of molecular weight being below 100 kDa in serological group A case and below 300 kDa in serological group C case by means of ultrafiltration on membranes. Then, 2% saturated sodium acetate solution is added to serological group A polysaccharide separated on membrane and the dissolved polysaccharide is sedimented with four volumes of 96% ethanol cooled to 4-5°C. The group C polysaccharide separated on membrane is subjected to ultracentrifuging at 100000 g during 2.5-3 h. The supernatant layer is separated. Dissolved polysaccharide is sedimented with four volumes of 96% ethanol cooled to 4-5°C.
EFFECT: increased high molecular weight polysaccharide content without drop in output performance.
4 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING IgAl-PROTEASE FROM SEROGROUP A NEISSERIA MENINGITIDIS AND RELATED IMMUNOGENIC PREPARATION | 2009 |
|
RU2407792C1 |
NUCLEIC ACID CODING FUNCTIONALLY ACTIVE RECOMBINANT IgAL PROTEASE NEISSERIA MENINGITIDIS OF SEROGROUP B, RECOMBINANT PLASMID DNA CONTAINING NUCLEOTIDE SEQUENCE CODING ACTIVE IgAL PROTEASE, PRODUCER STRAIN CONTAINING PLASMID DNA PRODUCING MATURE FORM OF IgAL PROTEASE, RECOMBINANT Ig PROTEASE NEISSERIA MENINGITIDIS OF SEROGROUP B, METHOD FOR PRODUCING MATURE FORM IgAL PROTEASE SHOWING IMMUNOGENIC AND PROTECTIVE PROPERTIES | 2011 |
|
RU2453599C1 |
METHOD OF VI-ANTIGEN PREPARING | 1998 |
|
RU2135208C1 |
HIGH-EFFECTIVE METHOD FOR BACTERIAL POLYSACCHARIDE PRODUCTION, PREPARATION OF CONJUGATE BASED THEREON AND IMMUNOGENIC COMPOSITION | 2013 |
|
RU2627156C2 |
METHOD FOR PREPARATION OF POLYSACCHARIDO-PROTEIN VACCINE AGAINST NEISSERIA MENINGITIS SEROGROUP B | 0 |
|
SU1750689A1 |
IMMUNOGENIC COMPOSITION | 2013 |
|
RU2634405C2 |
METHOD OF CLEANING BACTERIAL CAPSULAR POLYSACCHARIDE NEISSERIA MENINGITIDIS OR HAEMOPHILUS INFLUENZAE AND METHOD FOR PREPARING VACCINE | 2002 |
|
RU2381814C2 |
POLYNUCLEOTIDE ENCODING MUTANT RECOMBINANT IgA1 PROTEASE OF Neisseria meningitidis OF SEROGROUP B, RECOMBINANT PLASMID DNA COMPRISING SAID POLYNUCLEOTIDE, HOST CELL CONTAINING SAID PLASMID DNA, RECOMBINANT IgA1 PROTEASE OF Neisseria memingitidis OF SEROGROUP B, METHOD OF PRODUCING MATURE FORM OF IgA1 PROTEASE | 2011 |
|
RU2486243C1 |
METHOD OF PREPARING MENINGOCOCCUS LIPOPOLYSACCHARIDE OF SEROGROUP B | 1993 |
|
RU2089215C1 |
VACCINES OF SOLUBILISED AND COMBINED CAPSULAR POLYSACCHARIDES | 2002 |
|
RU2528066C2 |
Authors
Dates
2006-09-10—Published
2005-05-16—Filed